{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:25:37Z","timestamp":1788881137735,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd013457","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T00:00:00Z","timestamp":1613260800000}}],"reference-count":92,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013457.pub2","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T17:57:39Z","timestamp":1613325459000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder"],"prefix":"10.1002","volume":"2021","author":[{"given":"Swe Zin","family":"Aye","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health; Quest International University Perak; Ipoh Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Medicine; Newcastle University Medicine Malaysia; Johor Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Htwe H","family":"Sein","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health; Quest International University Perak; Ipoh Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San T","family":"Mon","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Newcastle University Medicine Malaysia; Johor Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Singapore Clinical Research Institute; Singapore Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko Kin Yoke","family":"Wong","sequence":"additional","affiliation":[{"name":"Cochrane Singapore; Singapore Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,2,14]]},"reference":[{"key":"10.1002\/14651858.CD013457.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13229-015-0062-8","article-title":"A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders","volume":"7","author":"Minshawi","year":"2016","journal-title":"Molecular Autism"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0002|cit2","unstructured":"D-cycloserine and social skills training in autism spectrum disorders clinicaltrials.gov\/ct2\/show\/NCT01086475"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13229-017-0116-1","article-title":"D-cycloserine enhances durability of social skills training in autism spectrum disorder","volume":"8","author":"Wink","year":"2017","journal-title":"Molecular Autism"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0004|cit4","unstructured":"Evaluating the effectiveness of Aripiprazole and D-cycloserine to treat symptoms associated with autism clinicaltrials.gov\/ct2\/show\/results\/NCT00198107"},{"issue":"11","key":"10.1002\/14651858.CD013457.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1176\/appi.ajp.161.11.2115","article-title":"A pilot study of D-cycloserine in subjects with autistic disorder","volume":"161","author":"Posey","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD013457.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1016\/S0006-3223(03)00164-1","article-title":"A pilot study of D-cycloserine in the treatment of autistic disorder","volume":"53","author":"Posey","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013457.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1176\/appi.neuropsych.13070155.","article-title":"A trial of D-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders","volume":"27","author":"Urbano","year":"2015","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"3","key":"10.1002\/14651858.CD013457.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/WNF.0000000000000033","article-title":"A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder","volume":"37","author":"Urbano","year":"2014","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"S505","DOI":"10.1038\/npp.2013.281","article-title":"A trial of D-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders","volume":"38","author":"Urbano","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0010|cit10","unstructured":"Safety and effectiveness of D-Cycloserine in children with autism clinicaltrials.gov\/ct2\/show\/study\/NCT00198120"},{"issue":"5","key":"10.1002\/14651858.CD013457.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2346","article-title":"Advances in autism genetics: on the threshold of a new neurobiology","volume":"9","author":"Abrahams","year":"2008","journal-title":"Nature Reviews. Genetics"},{"issue":"5","key":"10.1002\/14651858.CD013457.pub2-BIB0012|cit12","first-page":"485","article-title":"The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"American Journal of Mental Deficiency"},{"issue":"7","key":"10.1002\/14651858.CD013457.pub2-BIB0013|cit13","first-page":"592","article-title":"D-cycloserine for treatment of numbing and avoidance in chronic post traumatic stress disorder: a randomized, double blind, clinical trial","volume":"19","author":"Attari","year":"2014","journal-title":"Journal of Research in Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD013457.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1901\/jaba.1968.1-91","article-title":"Some current dimensions of applied behavior analysis","volume":"1","author":"Baer","year":"1968","journal-title":"Journal of Applied Behavior Analysis"},{"issue":"6","key":"10.1002\/14651858.CD013457.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6706a1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014","volume":"67","author":"Baio","year":"2018","journal-title":"Morbidity and Mortality Weekly Report - Surveillance Summaries"},{"issue":"2","key":"10.1002\/14651858.CD013457.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/092986709787002745","article-title":"Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders","volume":"16","author":"Blaylock","year":"2009","journal-title":"Current Medicinal Chemistry"},{"issue":"5","key":"10.1002\/14651858.CD013457.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/archgenpsychiatry.2011.38","article-title":"Epidemiology of autism spectrum disorders in adults in the community in England","volume":"68","author":"Brugha","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD013457.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/070674370805300710","article-title":"Prevalence of autism among adolescents with intellectual disabilities","volume":"53","author":"Bryson","year":"2008","journal-title":"Canadian Journal of Psychiatry [Revue Canadienne de Psychiatrie]"},{"issue":"7","key":"10.1002\/14651858.CD013457.pub2-BIB0019|cit19","first-page":"28","article-title":"The Clinical Global Impressions Scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0020|cit20","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1002\/14651858.CD013457.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13229-020-00336-3","article-title":"Sex differences in the first impressions made by girls and boys with autism","volume":"11","author":"Cola","year":"2020","journal-title":"Molecular Autism"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0022|cit22","volume-title":"The Social Responsiveness Scale","author":"Constantino","year":"2005"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0023|cit23","unstructured":"Covidence Veritas Health Innovation"},{"issue":"12","key":"10.1002\/14651858.CD013457.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.molmed.2011.07.008","article-title":"mTOR: a pathogenic signaling pathway in developmental brain malformations","volume":"17","author":"Crino","year":"2011","journal-title":"Trends in Molecular Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013457.pub2-BIB0025|cit25","first-page":"597","article-title":"Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications","volume":"50","author":"Danysz","year":"1998","journal-title":"Pharmacological Reviews"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch10"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0027|cit27","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1952"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0028|cit28","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0029|cit29","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-II)","author":"American Psychiatric Association","year":"1968"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0030|cit30","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0031|cit31","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0032|cit32","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"issue":"7109","key":"10.1002\/14651858.CD013457.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD013457.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","article-title":"Global prevalence of autism and other pervasive developmental disorders","volume":"5","author":"Elsabbagh","year":"2012","journal-title":"Autism Research"},{"issue":"8","key":"10.1002\/14651858.CD013457.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrn3978","article-title":"Immune mediators in the brain and peripheral tissues in autism spectrum disorder","volume":"16","author":"Estes","year":"2015","journal-title":"Nature reviews. Neuroscience"},{"issue":"1","key":"10.1002\/14651858.CD013457.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.6030\/1939-067x-3.1.8","article-title":"Clinical trial structures","volume":"3","author":"Evans","year":"2010","journal-title":"Journal of Experimental Stroke & Translational Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013457.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archpedi.161.4.343","article-title":"The lifetime distribution of the incremental societal costs of autism","volume":"161","author":"Ganz","year":"2007","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013457.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.neubiorev.2010.11.002","article-title":"Autism and ADHD: how far have we come in the comorbidity debate?","volume":"35","author":"Gargaro","year":"2011","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013457.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/archpsyc.56.1.21","article-title":"A placebo-controlled trial of d-cycloserine added to conventional neuroleptics in patients with schizophrenia","volume":"56","author":"Goff","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD013457.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.schres.2008.08.012","article-title":"Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study","volume":"106","author":"Goff","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1002\/14651858.CD013457.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/schbul\/sbs012","article-title":"D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia","volume":"38","author":"Goff","year":"2012","journal-title":"Schizophrenia Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD013457.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1177\/1362361317706174","article-title":"Towards understanding the under-recognition of girls and women on the autism spectrum","volume":"21","author":"Gould","year":"2017","journal-title":"Autism"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0043|cit43","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"4","key":"10.1002\/14651858.CD013457.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5607\/en.2015.24.4.273","article-title":"Characteristics of brains in autism spectrum disorder: structure, function and connectivity across the lifespan","volume":"24","author":"Ha","year":"2015","journal-title":"Experimental Neurobiology"},{"issue":"3","key":"10.1002\/14651858.CD013457.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1176\/appi.ajp.159.3.480","article-title":"Placebo-controlled trial of d-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia","volume":"159","author":"Heresco-Levy","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD013457.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1007\/s10803-018-3610-1","article-title":"The estimated prevalence of autism in school-aged children living in rural Nepal using a population-based screening tool","volume":"48","author":"Heys","year":"2018","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0047|cit47","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"Higgins JP Li T Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019) Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch6"},{"issue":"3","key":"10.1002\/14651858.CD013457.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008372.pub2","article-title":"Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents","author":"Hurwitz","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD013457.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.5588\/ijtld.12.0863","article-title":"Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis","volume":"17","author":"Hwang","year":"2013","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0051|cit51","volume-title":"International Statistical Classification of Diseases and Related Health Problems (ICD-10)","author":"World Health Organization","year":"2007"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0052|cit52","volume-title":"International Classification of Diseases for Mortality and Morbidity Statistics (ICD-11)","author":"World Health Organization","year":"2018"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0053|cit53","first-page":"217","article-title":"Autistic disturbances of affective contact","volume":"2","author":"Kanner","year":"1943","journal-title":"Nervous Child"},{"issue":"3","key":"10.1002\/14651858.CD013457.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/1362361309104246","article-title":"Economic cost of autism in the UK","volume":"13","author":"Knapp","year":"2009","journal-title":"Autism"},{"issue":"12","key":"10.1002\/14651858.CD013457.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1007\/s10803-015-2521-7","article-title":"Brief report: forecasting the economic burden of autism in 2015 and 2025 in the United States","volume":"45","author":"Leigh","year":"2015","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"6","key":"10.1002\/14651858.CD013457.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaac.2017.03.013","article-title":"What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis","volume":"56","author":"Loomes","year":"2017","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013457.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","article-title":"Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders","volume":"24","author":"Lord","year":"1994","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"3","key":"10.1002\/14651858.CD013457.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1005592401947","article-title":"The Autism Diagnostic Observation Schedule - Generic: a standard measure of social and communication deficits associated with the spectrum of autism","volume":"30","author":"Lord","year":"2000","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-publhealth-031816-044318","article-title":"The changing epidemiology of autism spectrum disorders","volume":"38","author":"Lyall","year":"2017","journal-title":"Annual Review of Public Health"},{"issue":"9","key":"10.1002\/14651858.CD013457.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s10803-017-3188-z","article-title":"The accuracy of the ADOS-2 in identifying autism among adults with complex psychiatric conditions","volume":"47","author":"Maddox","year":"2017","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"1","key":"10.1002\/14651858.CD013457.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cpr.2013.11.002","article-title":"Cognitive, language, social and behavioural outcomes in adults with autism spectrum disorders: a systematic review of longitudinal follow-up studies in adulthood","volume":"34","author":"Magiati","year":"2014","journal-title":"Clinical Psychology Review"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2015.11.003","article-title":"Risk factors in autism: thinking outside the brain","volume":"67","author":"Matelski","year":"2016","journal-title":"Journal of Autoimmunity"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0063|cit63","first-page":"9","article-title":"Neurochemistry in the pathophysiology of autism","volume":"66 Suppl 10","author":"McDougle","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13229-017-0121-4","article-title":"Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses","volume":"8","author":"Modabbernia","year":"2017","journal-title":"Molecular Autism"},{"issue":"7","key":"10.1002\/14651858.CD013457.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013457.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/schbul\/sbr016","article-title":"Eugen Bleuler's dementia praecox or the group of schizophrenias (1911): a centenary appreciation and reconsideration","volume":"37","author":"Moskowitz","year":"2011","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0067|cit67","unstructured":"D-cycloserine and social skills training in autism spectrum disorders clinicaltrials.gov\/ct2\/show\/NCT01086475"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0068|cit68","unstructured":"National Institute for Health and Care Excellence Autism spectrum disorder in under 19s: support and management nice.org.uk\/guidance\/cg170"},{"issue":"4","key":"10.1002\/14651858.CD013457.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10882-017-9547-z","article-title":"Stress among parents of children with and without autism spectrum disorder: a comparison involving physiological indicators and parent self-reports","volume":"29","author":"Padden","year":"2017","journal-title":"Journal of Developmental and Physical Disabilities"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch13"},{"issue":"10","key":"10.1002\/14651858.CD013457.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"e0186536","DOI":"10.1371\/journal.pone.0186536","article-title":"Family functioning, parenting stress and quality of life in mothers and fathers of Polish children with high functioning autism or Asperger syndrome","volume":"12","author":"Pisula","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1002\/14651858.CD013457.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.chc.2008.06.010","article-title":"Developing drugs for core social and communication impairment in autism","volume":"17","author":"Posey","year":"2008","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0073|cit73","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0074|cit74","unstructured":"Review Manager Web (RevMan Web) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"issue":"7","key":"10.1002\/14651858.CD013457.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"e93519","DOI":"10.1371\/journal.pone.0093519","article-title":"Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis","volume":"9","author":"Rodrigues","year":"2014","journal-title":"PloS One"},{"issue":"8","key":"10.1002\/14651858.CD013457.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00702-014-1216-0","article-title":"The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment","volume":"121","author":"Rojas","year":"2014","journal-title":"Journal of Neural Transmission"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/145359","article-title":"Autism in developing countries: lessons from Iran","volume":"2011","author":"Samadi","year":"2011","journal-title":"Autism Research and Treatment"},{"issue":"4","key":"10.1002\/14651858.CD013457.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"pii: pyv102","DOI":"10.1093\/ijnp\/pyv102","article-title":"D-cycloserine in neuropsychiatric diseases: a systematic review","volume":"19","author":"Schade","year":"2016","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD013457.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10803-017-3446-0","article-title":"Examining the links between challenging behaviors in youth with ASD and parental stress, mental health, and involvement: applying an adaptation of the Family Stress Model to families of youth with ASD","volume":"48","author":"Schiltz","year":"2018","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch15"},{"issue":"2","key":"10.1002\/14651858.CD013457.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0028-3908(01)00073-9","article-title":"Subunit specificity and mechanism of action of NMDA partial agonist d-cycloserine","volume":"41","author":"Sheinin","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0082|cit82","unstructured":"Scottish Intercollegiate Guidelines Network SIGN 145. Assessment, diagnosis and interventions for autism spectrum disorders. A national clinical guideline www.sign.ac.uk\/assets\/sign145.pdf"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0083|cit83","volume-title":"Vineland Adaptive Behavior Scales","author":"Sparrow","year":"2005"},{"issue":"11","key":"10.1002\/14651858.CD013457.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011144.pub2","article-title":"Methylphenidate for children and adolescents with autism spectrum disorder","author":"Sturman","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD013457.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.braindev.2010.05.007","article-title":"Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment","volume":"32","author":"Tuchman","year":"2010","journal-title":"Brain and Development"},{"issue":"3","key":"10.1002\/14651858.CD013457.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cpr.2009.01.003","article-title":"Anxiety in children and adolescents with autism spectrum disorders","volume":"29","author":"White","year":"2009","journal-title":"Clinical Psychology Review"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0087|cit87","unstructured":"World Health Organization Autistic spectrum disorder www.who.int\/news-room\/fact-sheets\/detail\/autism-spectrum-disorders"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1542\/peds.2012-0055I","article-title":"Standard 6: age groups for pediatric trials","volume":"129 Suppl 3","author":"Williams","year":"2012","journal-title":"Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD013457.pub2-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004677.pub3","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)","author":"Williams","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD013457.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"e0158688","DOI":"10.1371\/journal.pone.0158688","article-title":"Blood glutamate levels in autism spectrum disorder: a systematic review and meta-analysis","volume":"11","author":"Zheng","year":"2016","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD013457.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuropharm.2013.03.030","article-title":"NMDA receptors in nervous system diseases","volume":"74","author":"Zhou","year":"2013","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1002\/14651858.CD013457.pub2-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013457","article-title":"D-cycloserine for autism spectrum disorder","author":"Aye","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T09:02:07Z","timestamp":1734598927000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013457.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,14]]},"references-count":92,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013457.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,14]]}}}